Abstract

PV-0185: Retina dose as risk factor for worse visual outcome in 106Ru plaque brachytherapy of uveal melanoma

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Predictive factors of visual outcome in posterior segment intraocular foreign body.
Tzu-Yu Hou ... Ming-Hung Hsieh
Journal of the Chinese Medical Association : JCMA | VOL. 82
Tzu-Yu Hou, et. al.Tzu-Yu Hou ... Ming-Hung Hsieh
01 Mar 2019
Contact-Lens-Associated Purpureocillium Keratitis: Risk Factors, Microbiologic Characteristics, Clinical Course, and Outcomes
Derek W Delmonte ... Leejee H Suh
Seminars in Ophthalmology | VOL. 32
Derek W Delmonte, et. al.Derek W Delmonte ... Leejee H Suh
27 Feb 2015
Treatment Patterns and Visual Outcomes during the Maintenance Phase of Treat-and-Extend Therapy for Age-Related Macular Degeneration
Mark C Gillies ... Robyn H Guymer
Ophthalmology | VOL. 123
Mark C Gillies, et. al.Mark C Gillies ... Robyn H Guymer
20 Aug 2016
Retinal nerve fibre layer thinning is associated with worse visual outcome after optic neuritis in children with a relapsing demyelinating syndrome.
Wallace Brownlee ... Richard Bowman
Developmental medicine and child neurology | VOL. 60
Wallace Brownlee, et. al.Wallace Brownlee ... Richard Bowman
11 Apr 2018
View more papers

More From: Radiotherapy and Oncology

Paper Title
Journal
Date
Author
Contents
-
Radiotherapy and Oncology | VOL. 195
--
01 Jun 2024
Aims+Scope/Editorial Board/ Publication information
-
Radiotherapy and Oncology | VOL. 195
--
01 Jun 2024
Accuracy of machine learning in preoperative identification of genetic mutation status in lung cancer: A systematic review and meta-analysis
Jinzhan Chen ... Hongni Jiang
Radiotherapy and Oncology | VOL. 196
Jinzhan Chen, et. al.Jinzhan Chen ... Hongni Jiang
10 May 2024
Stereotactic radiotherapy vs whole brain radiation therapy in EGFR mutated NSCLC: Results & reflections from the prematurely closed phase III HYBRID trial
Ming Zeng ... Xing Luo
Radiotherapy and Oncology | VOL. -
Ming Zeng, et. al.Ming Zeng ... Xing Luo
01 May 2024
View more papers